Jeffrey Stein's Net Worth

$13.6 Million

Estimate Recalculated Sep 13, 2024 10:29PM EST

Who is Jeffrey Stein

Jeffrey Stein has an estimated net worth of $13.6 Million. This is based on reported shares across multiple companies, which include Trius Therapeutics Inc, IDEAYA Biosciences, Inc., Cidara Therapeutics, Inc., and Paratek Pharmaceuticals, Inc..

SEC CIK

Jeffrey Stein's CIK is 0001478831

Past Insider Trading and Trends

2021 was Jeffrey Stein's most active year for acquiring shares with 9 total transactions. Jeffrey Stein's most active month to acquire stocks was the month of February. 2023 was Jeffrey Stein's most active year for disposing of shares, totalling 10 transactions. Jeffrey Stein's most active month to dispose stocks was the month of August. 2018 saw Jeffrey Stein paying a total of $1,031,250.20 for 710,266 shares, this is the most they've acquired in one year. In 2013 Jeffrey Stein cashed out on 994,069 shares for a total of $9,549,668.09, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Trius Therapeutics Inc

President & CEO
Updated Sep 13, 2013
Form 4
-100.00%
-1.20M
$10.58
-$9.55M
Sep 13, 2013
Disposition
Sep 11
Form 4
275.00K
Mar 11, 2013
275.00K
Grant
Mar 07
Form 4
$0.52
$20.00K
Mar 28, 2012
291.74K
Options
Mar 27
Form 4
250.00K
Mar 12, 2012
250.00K
Grant
Mar 08
Form 4
$0.52
$11.80K
Dec 16, 2010
291.74K
Options
Dec 15
Form 4
200.00K
Nov 05, 2010
200.00K
Grant
Nov 03
Form 4
-21.20%
-40.17K
Aug 10, 2010
149.30K
Options
Aug 06
Form 3
Aug 02, 2010
144.01K
Showing 8 results

IDEAYA Biosciences, Inc.

Investor
Updated May 31, 2024
Form 4
16.20K
May 31, 2024
16.20K
Grant
May 31
Form 4
16.20K
Jun 09, 2023
16.20K
Grant
Jun 07
Form 4
11.00K
Jun 10, 2022
11.00K
Grant
Jun 09
Form 4
11.00K
Jun 16, 2021
11.00K
Grant
Jun 10
Form 4
11.00K
Jun 18, 2020
11.00K
Grant
Jun 16
Form 4
1.25K
Dec 19, 2019
1.25K
Grant
Sep 24
Form 3
May 22, 2019
11.01K
Showing 7 results

Cidara Therapeutics, Inc.

President & CEO
Updated Jun 11, 2024
Form 4
48.25%
8.00K
$13.21
$105.68K
Jun 11, 2024
84.56K
Purchase
Jun 07
Form 4
1.04M
Mar 20, 2024
2.57M
Grant
Mar 15
Form 4
-4.68%
-56.69K
$0.69
-$39.12K
Mar 12, 2024
1.53M
Tax
Mar 11
Form 4
17.76%
50.00K
$0.96
$47.89K
Aug 08, 2023
1.58M
Purchase
Aug 08
Form 4
87.60%
815.25K
Mar 29, 2023
2.07M
Grant
Mar 27
Form 4
21.59%
50.00K
$1.04
$51.86K
Mar 27, 2023
1.25M
Purchase
Mar 27
Form 4
155.70%
762.76K
$0.83
-$117.02K
Apr 04, 2022
1.53M
Grant
Mar 31
Form 4
Jan 07, 2022
783.49K
Options
Dec 29
Form 4
12.02%
50.00K
$1.59
$79.53K
Nov 15, 2021
739.49K
Purchase
Nov 12
Form 4
13.67%
50.00K
$1.74
$86.76K
Aug 19, 2021
689.49K
Purchase
Aug 18 - Aug 19
Form 4
2.84%
10.00K
Apr 05, 2021
635.49K
Grant
Mar 31
Form 4
525.00K
Mar 19, 2021
1.15M
Grant
Mar 17
Form 4
16.79%
50.00K
$2.00
$100.02K
Nov 12, 2020
621.49K
Purchase
Nov 10
Form 4
330.00K
Mar 23, 2020
330.00K
Grant
Mar 19
Form 4
$2.51
$100.00K
Jan 30, 2020
567.49K
Options
Jan 29
Form 4
30.33%
52.50K
$1.91
$100.10K
Sep 26, 2019
523.65K
Purchase
Sep 24
Form 4
Sep 16, 2019
521.15K
Options
Sep 12
Form 4
265.00K
Mar 22, 2019
265.00K
Grant
Mar 21
Form 4
-5.35%
-10.67K
Mar 13, 2019
457.15K
Grant
Feb 26
Form 4
60.00K
Feb 01, 2019
60.00K
Options
Jan 31
Form 4
-2.26%
-4.62K
Dec 04, 2018
467.82K
Grant
Nov 29
Form 4
833.00%
462.77K
$2.42
$1.03M
May 24, 2018
722.44K
Purchase
May 23
Form 4
235.00K
Apr 02, 2018
235.00K
Grant
Mar 29
Form 4
16.52%
7.35K
$6.79
$49.91K
Sep 12, 2017
255.97K
Purchase
Sep 12
Form 4
50.85%
15.00K
$5.95
$89.21K
Jun 07, 2017
248.62K
Purchase
Jun 05
Form 4
1,629.13%
232.90K
$7.75
$99.98K
Apr 04, 2017
451.31K
Purchase
Mar 31
Form 4
2.16%
4.31K
$11.51
$49.61K
May 23, 2016
215.80K
Purchase
May 20
Form 4
159.00K
Mar 18, 2016
159.00K
Grant
Mar 16
Form 4
6.70K
$15.09
$101.12K
Nov 27, 2015
206.09K
Purchase
Nov 24 - Nov 25
Form 4
420.00
$16.00
$6.72K
Apr 21, 2015
199.81K
Purchase
Apr 20
Form 3
Apr 14, 2015
199.39K
Showing 31 results

Paratek Pharmaceuticals, Inc.

Investor
Updated Sep 21, 2023
Form 4
-100.00%
-130.63K
Sep 21, 2023
Disposition
Sep 21
Form 4
-9.26%
-7.00K
$1.90
-$13.30K
Feb 23, 2023
68.63K
Sale
ScheduledFeb 21
Form 4
35.96%
20.00K
Feb 09, 2023
75.63K
Grant
Feb 08
Form 4
56.14%
20.00K
Feb 18, 2022
55.63K
Grant
Feb 16
Form 4
60.09%
16.00K
Feb 22, 2021
42.63K
Grant
Feb 18
Form 4
90.78%
16.00K
Feb 21, 2020
33.63K
Grant
Feb 19
Form 4
123.46%
12.50K
Feb 28, 2019
22.63K
Grant
Feb 26
Form 4
-25.00%
-3.38K
$7.14
-$24.10K
Feb 20, 2019
10.13K
Sale
ScheduledFeb 15
Form 4
208.33%
12.50K
Feb 16, 2018
18.50K
Grant
Feb 14
Form 4
12.00K
Feb 06, 2017
12.00K
Grant
Feb 02
Form 4
12.00K
Feb 08, 2016
12.00K
Grant
Feb 04
Form 4
20.00K
Feb 06, 2015
20.00K
Grant
Feb 04
Form 3
Nov 03, 2014
Showing 13 results